Circulating inflammatory proteins associate with response to immune checkpoint inhibition therapy in patients with advanced melanoma. (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ebiom.2022.104235
PubMed Identifier: 36007304
Publication URI: http://europepmc.org/abstract/MED/36007304
Type: Journal Article/Review
Volume: 83
Parent Publication: EBioMedicine
ISSN: 2352-3964